Načítá se...
Use of Edoxaban for the Treatment of Heparin-Induced Thrombocytopenia
Heparin-induced thrombocytopenia (HIT) is a life-threatening adverse drug reaction of heparin therapy, which increases a patient's risk of developing venous and/or arterial thromboembolism. HIT should be treated through discontinuation of heparin and administration of nonheparin anticoagulants...
Uloženo v:
| Vydáno v: | Case Rep Vasc Med |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7492919/ https://ncbi.nlm.nih.gov/pubmed/32963878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/2367095 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|